Ovarian cancer

• Health & Medicine

Cancer Research UK scientists discover pattern of genetic faults to predict cancer drug success

A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences* today (Monday). A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences* today (Monday).

4 May 2009

• Health & Medicine

Early results from ovarian cancer screening trial look promising

12 March 2009

• Science & Technology

Oestrogen causes DNA mutations – is this how it fuels cancer?

12 January 2009

• Health & Medicine

Ovarian cancer – spotting the “silent killer”

21 November 2008

Scientists find DNA repair 'scissors' after 18 year hunt

Cancer Research UK scientists have identified a long sought after enzyme that plays a critical role in a DNA repair pathway linked with inheritable breast and ovarian cancer, reveals research published in Nature* today (Wednesday). Cancer Research UK scientists have identified a long sought after enzyme that plays a critical role in a DNA repair pathway linked with inheritable breast and ovarian cancer, reveals research published in Nature* today (Wednesday).

19 November 2008

Talcum powder and ovarian cancer - what's going on?

5 October 2008

• Health & Medicine

Viruses in disguise could be key to ovarian cancer treatment

30 July 2008

• Science & Technology
• Health & Medicine

A 'lethal weapon' in the search for new cancer treatments?

10 July 2008

• Science & Technology
• Health & Medicine

Aspirin's a 'wonder-drug' - but can it prevent cancer?

13 May 2008

New drug trial to target hereditary cancers

Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer. Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer.

27 February 2008

• Health & Medicine

The pill gives long-lasting protection against ovarian cancer

The contraceptive Pill gives women substantial and long-lasting protection against ovarian cancer, according to a new report by Cancer Research UK scientists in The Lancet today (Friday Jan 25th). The contraceptive Pill gives women substantial and long-lasting protection against ovarian cancer, according to a new report by Cancer Research UK scientists in The Lancet today (Friday Jan 25th).

25 January 2008

• Health & Medicine

Missing protein provides clue to ovarian cancer drug success

Scientists have discovered a protein which could improve the success rate of the tumour shrinking drug paclitaxel, in the treatment of ovarian cancer, a study reveals in Cancer Cell. Scientists have discovered a protein which could improve the success rate of the tumour shrinking drug paclitaxel, in the treatment of ovarian cancer, a study reveals in Cancer Cell.

10 December 2007